© 2020 MJH Life Sciences and Endocrinology Network. All rights reserved.
© 2020 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
April 4th 2017
Men’s health studies presented at ENDO 2017 included a possible prostate cancer treatment and the potential of hormone therapy to prevent frailty.
April 3rd 2017
Researchers sought to discover the specific physiological pathways of fibroblast growth factor 21.
Research presented at ENDO 2017 explored options to reduce complications in patients with diabetes and microalbuminuria and patients with cystic fibrosis.
April 2nd 2017
Researchers investigated possible differences in the function of the striatum both before and after the development of obesity.
Studies presented at ENDO 2017 examined the impact of sleep disorders on gestational diabetes, bone formation, and adolescents with and without diabetes.
March 31st 2017
You won’t want to miss these top sessions and new features at this year’s Endocrinology Society’s annual meeting, April 1-4, in Orlando, FL.
July 20th 2016
Follow-up data from the landmark Diabetes Prevention Study examined the role of physical activity in diabetes prevention.
July 12th 2016
This slideshow highlights several studies regarding the effects of SGLT2 inhibitors, which were presented at the 2016 ADA Scientific Sessions.
July 1st 2016
Several studies presented at ADA 2016 discussed going beyond basal insulin treatments for patients with type 2 diabetes.
June 16th 2016
A secondary analysis of data from the Insulin Resistance Intervention after Stroke trial (IRIS) examined pioglitazone’s effect on diabetes prevention.